Anne Dixon, MD
Enriched profileE.L. Amidon Chair and Professor of Medicine; Chair, Department of Medicine, Larner College of Medicine, University of Vermont · University of Vermont Larner College of Medicine
Anne Dixon is E.L. Amidon Chair and Professor of Medicine; Chair, Department of Medicine, Larner College of Medicine, University of Vermont at University of Vermont Larner College of Medicine. OpenAlex indexes 244 publications with 9,091 citations (h-index 47); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Anne Dixon, MD, is E.L. Amidon Chair and Professor of Medicine at University of Vermont Larner College of Medicine. The public record shows 244 publications with 9,091 citations (h-index 47), centered on Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory and Cough-Related Research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 3 companies, 9 NIH-funded awards (2004–2022).
- Most recent indexed publication: 2026 · Annals of the American Thoracic Society
- Top research focus: Asthma and respiratory diseases
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 101.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Sponsor: Johns Hopkins University
- Accelerated Pulmonary Rehabilitation in the Preoperative Period
Sponsor: University of Vermont
- MitoQ for the Treatment of Metabolic Dysfunction in Asthma
Sponsor: University of Vermont
Industry payments
Updated 27 Aug 2026
3 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20241 payment
- CSL BehringProgram year20212 payments
- United Therapeutics CorporationProgram year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
34.8%Corticosteroid16.8%Symbicort50%Trelegy Ellipta50%Part D<11 patientsPhosphodiesterase 4 Inhibitor10.3%Roflumilast100%Part D<11 patientsMetabolism & gastrointestinal
34.2%Corticosteroid27.1%Prednisone100%Part D≥14 patientsH2 blocker7.1%Famotidine100%Part D<11 patientsAnti-infectives
18.7%Macrolide Antimicrobial10.3%Azithromycin100%Part D<11 patientsShort-acting sulfonamides8.4%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 2004–2022 per NIH RePORTER. The latest:
- Mitochondrial Redox Perturbations in Obese Allergic Asthma
University of Vermont & St Agric College
FY2022$780,069R01HL136917 - Mitochondrial Redox Perturbations in Obese Allergic Asthma
University of Vermont & St Agric College
FY2021$767,958R01HL136917 - Obese Allergic Asthma and the Impact of Weight Loss on Airway Epithelial Function
University of Vermont & St Agric College
FY2020$775,680R01HL133920
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Respiratory Adverse Events of Weight-Loss Drugs: A Systematic Review and Meta-Analysis.
Annals of the American Thoracic Society
Article2026 - The challenge of addressing obesity in people with poorly controlled asthma.
Obesity science & practice
Article2021 - Dysregulation of Pyruvate Kinase M2 Promotes Inflammation in a Mouse Model of Obese Allergic Asthma.
American journal of respiratory cell and molecular biology
Article2021 - Pyruvate Kinase M2 Promotes Expression of Proinflammatory Mediators in House Dust Mite-Induced Allergic Airways Disease.
Journal of immunology (Baltimore, Md.
Article2020
Most-cited works
by citation count (OpenAlex)- 01Obesity and asthmaArticle915 citations2018
- 02The effect of obesity on lung functionArticle895 citations2018
- 03
- 04
- 05An Official American Thoracic Society Workshop Report: Obesity and AsthmaArticle351 citations2010
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/Anne-E-Dixon-38487412
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
hstalks.com/expert/2064/prof-anne-dixon
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hstalks.com ↗ - Other
lung.org/about-us/our-leadership/anne-e-dixon-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗ - Other
lung.org/professional-education/lungcast/episode-32
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →comis.med.uvm.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →comis.med.uvm.edu ↗
- M.D. credential (US equivalent of Oxford B.M., B.Ch.)
as used in US clinical practice
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗ - Board certified
Pulmonary Disease and Critical Care Medicine (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Member
Expert Panel Working Group, National Asthma Education and Prevention Program Coordinating Committee (NHLBI) -- 2020 Focused Updates to the Asthma Management Guidelines
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jacionline.org ↗ - Fellow
American Thoracic Society
- Chair
Pulmonary Examination Committee, American Board of Internal Medicine
Awards & honors
honors on the public record- Champion of the Asthma & Allergy Community Award
New England Chapter of the Asthma and Allergy Foundation of America
2021
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm